Pulmonary Fibrosis

Pulmonary Fibrosis Causes

Pulmonary Fibrosis Causes

In many cases, pulmonary fibrosis develops with no known causes. This progressive condition, which is associated with the thickening, stiffening and scarring of tissue deep within the lungs, can lead to breathing difficulties that worsen over time. This can prevent the body from getting enough oxygen and eventually lead to respiratory failure and other serious complications.

Sometimes, a physician can identify the source of lung damage. For instance, some cases result from prolonged exposure to lung irritants that are naturally present in the environment, byproducts of certain occupations or agents of particular medications. Genetic factors and certain medical conditions are also believed to play a role in the development of lung scarring. Finally, exposure to tobacco smoke is known to significantly worsen all lung conditions, including pulmonary fibrosis.

Specifically, researchers have identified multiple pulmonary fibrosis causes to date, including:

  • Environmental factors – Bird and animal waste
  • Occupational factors – Silica dust, asbestos fibers, grain dust, burn pits and herbicides
  • Medication-related factors – Radiation, chemotherapy agents, antiarrhythmics, antibiotics and anticonvulsants
  • Autoimmune/connective tissue disorders – Scleroderma, lupus, rheumatoid arthritis and polymyositis
  • Severe infections – Certain viruses and bacterial infections

Scientists continue to investigate other possible pulmonary fibrosis causes, as well as new treatment options to slow the decline of lung function, relieve breathing difficulties caused by lung scarring and promote the best possible quality of life. Cellular therapy is an alternative treatment for pulmonary fibrosis offered by the Lung Institute. As a world-recognized leader in regenerative medicine focused exclusively on treating lung conditions, we’ve created a new source of hope for some patients who depend on supplemental oxygen or face challenges in performing daily tasks.

While a diagnosis of pulmonary fibrosis causes dismay for some individuals, all hope is not lost for those affected by this condition. Contact the Lung Institute at (800) 729-3065 and let our caring team can explain how cellular therapy may help you breathe easier and get back to the activities you enjoy.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.